The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs
This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM Foundation. Looking at the data from clinical trials of new GLP-1 agonists, it’s clear that patients will need to stay on the drugs to maintain their weight loss, experts said. …
The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs Read More »